Marios Spanakis, PharmD, PhD
Marios Spanakis, PharmD, PhD
Collaborating Researcher at FORTH-ICS, Computational BioMedicine Lab
Verified email at - Homepage
Cited by
Cited by
Controlled release of 5-fluorouracil from microporous zeolites
M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014
Potential drug–drug interactions in prescriptions dispensed in community pharmacies in Greece
A Chatsisvili, I Sapounidis, G Pavlidou, E Zoumpouridou, VA Karakousis, ...
Pharmacy world & science 32 (2), 187-193, 2010
Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic …
M Spanakis, S Kasmas, I Niopas
Biomedical Chromatography 23 (2), 124-131, 2009
Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal …
V Kimiskidis, M Spanakis, I Niopas, D Kazis, C Gabrieli, FI Kanaze, ...
Journal of pharmaceutical and biomedical analysis 43 (2), 763-768, 2007
Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits
M Spanakis, IS Vizirianakis, G Batzias, I Niopas
Pharmacology 91 (1-2), 112-116, 2013
Determination of atenolol in human plasma by HPLC with fluorescence detection: validation and application in a pharmacokinetic study
M Spanakis, I Niopas
Journal of chromatographic science 51 (2), 128-132, 2013
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological …
M Spanakis, IS Vizirianakis, I Mironidou-Tzouvelekib, Maria, Niopas
Biomed. Chromatogr 23, 1131-1137, 2009
Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery
C Karavasili, M Spanakis, D Papagiannopoulou, IS Vizirianakis, ...
Journal of pharmaceutical sciences 104 (7), 2304-2311, 2015
Secure access to patient's health records using SpeechXRays a mutli-channel biometrics platform for user authentication
EG Spanakis, M Spanakis, A Karantanas, K Marias
2016 38th Annual International Conference of the IEEE Engineering in …, 2016
Designing a digital patient avatar in the context of the MyHealthAvatar project initiative
E Maniadi, H Kondylakis, EG Spanakis, M Spanakis, M Tsiknakis, ...
13th IEEE international conference on BioInformatics and BioEngineering, 1-4, 2013
PharmActa: empowering patients to avoid clinical significant drug–herb interactions
M Spanakis, S Sfakianakis, V Sakkalis, EG Spanakis
Medicines 6 (1), 26, 2019
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
I Triviai, S Zeschke, J Rentel, M Spanakis, T Scherer, R Gabdoulline, ...
Leukemia 33 (1), 99-109, 2019
Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics
IS Vizirianakis, GA Mystridis, K Avgoustakis, DG Fatouros, M Spanakis
Oncology reports 35 (4), 1891-1904, 2016
Clinical and pharmacogenomic assessment of herb-drug interactions to improve drug delivery and pharmacovigilance
IS Vizirianakis, M Spanakis, A Termentzi, I Niopas, E Kokkalou
Plants in traditional and modern medicine: chemistry and activity, 978-81, 2010
GC–MS Simultaneous determination of enalapril and enalaprilat in human plasma: Application to a clinical pharmacokinetic study
M Spanakis, I Niopas
Chromatographia 72 (9), 957-962, 2010
PharmActa: Personalized pharmaceutical care eHealth platform for patients and pharmacists
M Spanakis, S Sfakianakis, G Kallergis, EG Spanakis, V Sakkalis
Journal of biomedical informatics 100, 103336, 2019
Personalized mobile ehealth services for secure user access through a multi feature biometric framework
GC Manikis, M Spanakis, EG Spanakis
International Journal of Reliable and Quality E-Healthcare (IJRQEH) 8 (1), 40-51, 2019
Assessment of DCE–MRI parameters for brain tumors through implementation of physiologically–based pharmacokinetic model approaches for Gd-DOTA
M Spanakis, E Kontopodis, S Van Cauter, V Sakkalis, K Marias
Journal of pharmacokinetics and pharmacodynamics 43 (5), 529-547, 2016
In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform
M Spanakis, K Marias
In silico pharmacology 2 (1), 1-9, 2014
PDCA: An eHealth service for the management of drug interactions with complementary and alternative medicines
M Spanakis, S Sfakianakis, EG Spanakis, G Kallergis, V Sakkalis
2018 IEEE EMBS International Conference on Biomedical & Health Informatics …, 2018
The system can't perform the operation now. Try again later.
Articles 1–20